Pharmaceuticals, Biotechnology and Life Sciences
Global oligonucleotide synthesis market is expected to reach $2.9billion by 2024, at a CAGR of 10.5% during the forecast period of 2019to 2024.
The global influenza vaccines market size is expected to surpass USD 6billion by 2025.
Due to an increase in the incidence of medical ailments, the marketstudied is expected to grow over the forecast period.
The global food enzymes market is expected to grow at a CAGR of 7.5%from 2019 to reach $3,125.1 million by 2024 from $2,176.9 million in2019.
Recipharm, the contract development and manufacturing organisation (CDMO), has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.
Transgene Combined General Meeting (ordinary and extraordinary sessions) ofTransgene’s shareholders will be held on May 22, 2019,
The European Commission (EC) has licensed Dupixent (dupilumab), developed by Regeneron and Sanofi, for older than 12 patients as an add-on maintenance treatment for severe asthma with type 2 inflammation.
GERMANY-based contract development and manufacturing organization (CDMO) Vibalogics has increased its single-use bioreactor and purification capacity with a new manufacturing line to meet increasing demand for its specialist oncolytic virus and viral vector manufacturing services.
Takeda sells Xiidra to Novartis for up to$5.3 billion, TachoSil to Ethicon for approximately $400 million
Promethera doses patients with HepaStem drug testing it in late stage non-alcoholic steatohepatitis